Probiotics, insulin, and inflammation

In this study, 72 women with gestational diabetes took a placebo or a combination of eight probiotics including S. thermophiles, B. breve, B. longum, B. infantis, L. acidophilus, L. plantarum, L. paracasei, and L. bulgaricus. After eight weeks, while the placebo group had not improved, women taking the probiotics saw insulin levels decline, and insulin resistance decrease.

Researchers also measured inflammation and found significant decreases in a sign of systemic inflammation: high-sensitivity C-reactive protein, and in two other inflammation markers, IL-6 and TNS alpha. Doctors said the findings suggest probiotics can reduce inflammation and benefit glycemic control in women with gestational diabetes.

Previous Back to Top
More Related Articles